Experimental Cell Research
Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease
Experiments in miceMechanisms
- Glycolysis
- mTOR signalling
- Oxidative phosphorylation
- Asymmetric dimethylarginine
- Chronic kidney disease
- Humans
The paper
Army Medical University
Experimental Cell Research, 2 Oct 2026


